PMC8114254_01
(a and b) Brain magnetic resonance imaging showed cerebral sinus venous thrombosis (arrows) in the superior sagittal sinus. (a) Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (Gd-DTPA)-enhanced T1-weighted imaging and (b) diffusion-weighted imaging. (c and d) Brain magnetic resonance imaging performed at the end of the induction therapy showed a cerebral sinus venous thrombosis. The arrow indicates a residual lesion. (c) T1-weighted imaging and (d) fluid attenuated inversion recovery (FLAIR) imaging.
10.1177_2050313X211013225-fig1.jpg
PMC8114254_01_10.1177_2050313X211013225-fig1.jpg
fig1-2050313X211013225
MRI performed on day 21 after the initiation of ALL treatment showed a CSVT in the superior sagittal sinus (Figure 1(a) and (b)). The patient achieved complete remission after the completion of the induction therapy, and the follow-up brain MRI performed at the end of the induction therapy showed that the CSVT had been ameliorated (Figure 1(c) and (d)).